These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 3818316)
1. Biodistribution of N-alkyl and N-fluoroalkyl derivatives of spiroperidol; radiopharmaceuticals for PET studies of dopamine receptors. Welch MJ; Chi DY; Mathias CJ; Kilbourn MR; Brodack JW; Katzenellenbogen JA Int J Rad Appl Instrum B; 1986; 13(5):523-6. PubMed ID: 3818316 [TBL] [Abstract][Full Text] [Related]
2. N-(3-[18F]fluoropropyl)-spiperone: the preferred 18F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor. Welch MJ; Katzenellenbogen JA; Mathias CJ; Brodack JW; Carlson KE; Chi DY; Dence CS; Kilbourn MR; Perlmutter JS; Raichle ME Int J Rad Appl Instrum B; 1988; 15(1):83-97. PubMed ID: 3258305 [TBL] [Abstract][Full Text] [Related]
3. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors. Yang ZY; Perry B; Mukherjee J Nucl Med Biol; 1996 Aug; 23(6):793-805. PubMed ID: 8940723 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of no-carrier-added N-([18F]fluoroalkyl)spiperone derivatives. Chi DY; Kilbourn MR; Katzenellenbogen JA; Brodack JW; Welch MJ Int J Rad Appl Instrum A; 1986; 37(12):1173-80. PubMed ID: 3028983 [TBL] [Abstract][Full Text] [Related]
5. 3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet. Coenen HH; Laufer P; Stöcklin G; Wienhard K; Pawlik G; Böcher-Schwarz HG; Heiss WD Life Sci; 1987 Jan; 40(1):81-8. PubMed ID: 2948091 [TBL] [Abstract][Full Text] [Related]
6. No-carrier-added N-(3-[18F]fluoropropyl)spiroperidol: biodistribution in mice and tomographic studies in a baboon. Shiue CY; Bai LQ; Teng RR; Arnett CD; Wolf AP J Nucl Med; 1987 Jul; 28(7):1164-70. PubMed ID: 3496434 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of N-alkyl derivatives of radioiodinated spiperone as radioligands for in vivo dopamine D2 receptor studies: effects of lipophilicity and receptor affinity on the in vivo biodistribution. Saji H; Tokui T; Nakatsuka I; Saiga A; Magata Y; Shiba K; Yoshitake A; Yokoyama A Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):165-9. PubMed ID: 1576667 [TBL] [Abstract][Full Text] [Related]
8. Syntheses and D2 receptor affinities of derivatives of spiperone containing aliphatic halogens. Kiesewetter DO; Eckelman WC; Cohen RM; Finn RD; Larson SM Int J Rad Appl Instrum A; 1986; 37(12):1181-8. PubMed ID: 3028984 [TBL] [Abstract][Full Text] [Related]
9. Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor. Welch MJ; Kilbourn MR; Mathias CJ; Mintun MA; Raichle ME Life Sci; 1983 Oct; 33(17):1687-93. PubMed ID: 6633162 [TBL] [Abstract][Full Text] [Related]
10. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans. Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146 [TBL] [Abstract][Full Text] [Related]
11. [18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain. Arnett CD; Fowler JS; Wolf AP; Shiue CY; McPherson DW Life Sci; 1985 Apr; 36(14):1359-66. PubMed ID: 3872397 [TBL] [Abstract][Full Text] [Related]
12. Effect of lipophilicity on the in vivo localization of radiolabelled spiperone analogues. Moerlein SM; Laufer P; Stöcklin G Int J Nucl Med Biol; 1985; 12(5):353-6. PubMed ID: 3833821 [TBL] [Abstract][Full Text] [Related]
13. Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. Mukherjee J; Yang ZY; Das MK; Brown T Nucl Med Biol; 1995 Apr; 22(3):283-96. PubMed ID: 7627142 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of omega-[18F]fluoroalkyl analogs of YM-09151-2 for the measurement of D2-dopamine receptors with PET. Hatano K; Ido T; Ishiwata K; Hatazawa J; Itoh M; Kawashima K; Iwata R Int J Rad Appl Instrum A; 1990; 41(6):551-5. PubMed ID: 2163373 [TBL] [Abstract][Full Text] [Related]
15. Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography. Arnett CD; Shiue CY; Wolf AP; Fowler JS; Logan J; Watanabe M J Neurochem; 1985 Mar; 44(3):835-44. PubMed ID: 2579198 [TBL] [Abstract][Full Text] [Related]
16. [18F]spiroperidol: a radiopharmaceutical for the in vivo study of the dopamine receptor. Welch MJ; Raichle ME; Kilbourn MR; Mintun MA Ann Neurol; 1984; 15 Suppl():S77-8. PubMed ID: 6611130 [No Abstract] [Full Text] [Related]
17. PET measurement of D2 and S2 receptor binding of 3-N-[( 2'-18F]fluoroethyl)spiperone in baboon brain. Coenen HH; Wienhard K; Stöcklin G; Laufer P; Hebold I; Pawlik G; Heiss WD Eur J Nucl Med; 1988; 14(2):80-7. PubMed ID: 2968911 [TBL] [Abstract][Full Text] [Related]
18. N-(3-[18F]fluoropropyl)-N-nordiprenorphine: synthesis and characterization of a new agent for imaging opioid receptors with positron emission tomography. Chesis PL; Hwang DR; Welch MJ J Med Chem; 1990 May; 33(5):1482-90. PubMed ID: 2158564 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vivo evaluation of [18F]-N-(p-nitrobenzyl)spiperone ([18F]PNBS) in rats. Mach RH; Nowak PA; Moroney DA; Morton TE; Jackson JR; Ehrenkaufer RL Nucl Med Biol; 1993 Apr; 20(3):269-78. PubMed ID: 8485486 [TBL] [Abstract][Full Text] [Related]
20. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. Goodman MM; Kilts CD; Keil R; Shi B; Martarello L; Xing D; Votaw J; Ely TD; Lambert P; Owens MJ; Camp VM; Malveaux E; Hoffman JM Nucl Med Biol; 2000 Jan; 27(1):1-12. PubMed ID: 10755640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]